Evidence map›Paper›PMID 23503203›Full record

ArticleEpigenetics2013

Cigarette smoke induces methylation of the tumor suppressor gene NISCH.

Kimberly Laskie Ostrow, Christina Michailidi, Rafael Guerrero-Preston, Mohammad O Hoque, Alissa Greenberg, William Rom, David Sidransky

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. mApplied biochemistry and biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Promoter Methylation of TwoAddiction & health · 2023
    Article
  7. Review
  8. Article
  9. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Review
  10. EvaluatingIndian journal of clinical biochemistry : IJCB · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Kimberly Laskie OstrowDepartment of Otolaryngology; Head and Neck Cancer Research Division; Johns Hopkins School of Medicine; Baltimore, MD USA.
Christina MichailidiDepartment of Otolaryngology; Head and Neck Cancer Research Division; Johns Hopkins School of Medicine; Baltimore, MD USA.
Rafael Guerrero-PrestonDepartment of Otolaryngology; Head and Neck Cancer Research Division; Johns Hopkins School of Medicine; Baltimore, MD USA.
Mohammad O HoqueDepartment of Otolaryngology; Head and Neck Cancer Research Division; Johns Hopkins School of Medicine; Baltimore, MD USA.
Alissa GreenbergDepartment of Medicine; New York University; New York, NY USA.
William RomDepartment of Medicine; New York University; New York, NY USA.
David SidranskyDepartment of Otolaryngology; Head and Neck Cancer Research Division; Johns Hopkins School of Medicine; Baltimore, MD USA.
University of Baltimore · USJohns Hopkins Medicine · USJohns Hopkins University · USNew York Proton Center · USNew York University · US

Funding

INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MARKERSU01CA084986 · NCI · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 1999 to 2014
$33.8M
NYU Lung Cancer Biomarker CenterU01CA086137 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROM, WILLIAM N · 2000 to 2015
$15.3M
Epigenomic Markers of HNSCC Survival Across Ethnic GroupsK01CA164092 · NCI · JOHNS HOPKINS UNIVERSITY · PI GUERRERO-PRESTON, RAFAEL · 2011 to 2014
$530k
NCI NIH HHS EDRN U01 CA086137NCI NIH HHS K01 CA164092NCI NIH HHS U01 CA084986NCI NIH HHS U01-CA084986
6 · The paper itself

Abstract

We have previously identified a putative tumor suppressor gene, NISCH, whose promoter is methylated in lung tumor tissue as well as in plasma obtained from lung cancer patients. NISCH was observed to be more frequently methylated in smoker lung cancer patients than in non-smoker lung cancer patients. Here, we investigated the effect of tobacco smoke exposure on methylation of the NISCH gene. We tested methylation of NISCH after oral keratinocytes were exposed to mainstream and side stream cigarette smoke extract in culture. Methylation of the promoter region of the NISCH gene was also evaluated in plasma obtained from lifetime non-smokers and light smokers (<20 pack/year), with and without lung tumors, and heavy smokers (20+ pack/year) without disease. Promoter methylation of NISCH was tested by quantitative fluorogenic real-time PCR in all samples. Promoter methylation of NISCH occurred after exposure to mainstream tobacco smoke as well as to side stream tobacco smoke in normal oral keratinocyte cell lines. NISCH methylation was also detected in 68% of high-risk, heavy smokers without detectable tumors. Interestingly, in light smokers, NISCH methylation was present in 69% of patients with lung cancer and absent in those without disease. Our pilot study indicates that tobacco smoke induces methylation changes in the NISCH gene promoter before any detectable cancer. Methylation of the NISCH gene was also found in lung cancer patients' plasma samples. After confirming these findings in longitudinally collected plasma samples from high-risk populations (such as heavy smokers), examining patients for hypermethylation of the NISCH gene may aid in identifying those who should undergo additional screening for lung cancer.

Indexed as

AdultAgedCohort StudiesDNA MethylationFemaleGenes, Tumor SuppressorHumansImidazoline ReceptorsIntracellular Signaling Peptides and ProteinsKeratinocytesLung NeoplasmsMaleMiddle AgedPromoter Regions, GeneticSmokingTobacco ProductsImidazoline ReceptorsIntracellular Signaling Peptides and ProteinsNISCH protein, humanlung cancermethylationNischsmokingtobacco

Identifiers

PMID23503203
PMCPMC3674047
OpenAlexW2084582175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.